Author
Why the next big hope for Alzheimer’s might not help most Black patients
The FDA on Thursday gave full approval to what many scientists and doctors believe is the first drug to show promise of slowing the progression of Alzheimer’s disease. But while patient advocates are celebrating, critics see it as the unfortunate triumph of a flawed theory of the disease’s cause and predict the rollout of the […]